Leverkusen, North Rhine-Westphalia, Germany
Background in product development & life cycle management projects (cost improvements, reformulations, manufacturing site transfers, regulatory compliance). Working with internal plants and external manufacturers in EU markets as well as Middle East, Africa and Russia. Regulatory support for biocidal product registrations, OTC drugs, cosmetic products. Biocides, cosmetic formulations, pharmaceutical/ OTC products, sanitary protection & nonwovens. Project management skills and people management/ people development experience. Hands on and results oriented. Spezialgebiete: Biocides, preservatives, cosmetic formulations (leave-on &rinse-off for babies, kids and adults as well as oral care formulations), pharmaceutical products (OTC, all dosage forms incl. sterile products), sanitary protection products, nonwoven products, food.
Customer support for biocides for industrial applications Regulatory support for active substance and biocidal product registrations Management of internal/ external efficacy studies Product development of new biocidal products
Responsibility for all non-OTC life cycle management projects in the EMEA region Key achievements: - Managed the reformulation program of a regional intiative to reposition the complete J&J Beauty portfolio (> 120 formulations, projected CIP > 4MM $) - Reformulation of complete bar soap portfolio incl. change of soap noodle blend (CIP > 1MM $/ year)
Responsibility for all non-OTC life cycle management projects in the emerging markets of the EMEA region (Russia, Middle East, Africa) Key achievements: - Setting up local production in Russia, South Africa and Nigeria for Johnson‘s Baby, Le Petit Marseillais and other key brands (cost improvement >4MM $/year) - Reformulation of Tgel shampoo range with new formula, fragrance and new efficacy claims (>1MM $ CIP)
Cost improvement, business continuity and regulatory compliance projects for all CHC brands incl. Listerine mouthwashes, Visine eye drops, Regaine and other cosmetic, pharmaceutical and medical device products. Key achievements: - Double sourcing of all key Listerine raw materials in 2009/2010 (NTS protection and cost improvement >2.5MM $/year) - Harmonization/ optimization of CHC oral care portfolio in 2011 (toothpaste, mouthwashes, floss and toothbrushes) excl. Listerine to ensure regulatory compliance. Cost imporvements and portfolio optimization >2MM $/year - Several manufacturing site transfers for key OTC products to external manufacturers in EMEA (cost improvements >5MM $/year) in the years 2009-2014